Role of MSCT of Chest in Differentiation Between COPD Patients According to Their Smoking Status

NCT ID: NCT05475977

Last Updated: 2022-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-31

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality all over the world. Smoking is considered as an important risk factor, but other risk factors are present. Around 30 % of patients with COPD are non-smokers.

Cessation of smoking in patients with COPD causes decreases the presence of micronodules and other criteria of CT chest.

In last few years, some researchers reported that cessation of smoking raise the apparent extent of emphysema. The cause is not obvious, but this paradoxical fall in lung density is thaught to be resulting from decrease in inflammation after smoking cessation.

CT chest criteria of COPD in active smokers, non-smokers and ex-smokers seem to be different.

So, comparison between CT chest Criteria of COPD in smokers, ex-smokers and non-smokers will be searched in this study to detect the role of multislice computed tomography (MSCT) chest in differentiation between COPD patients according to their smoking status.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Basic ethical principles of medical research; beneficence (do well), non-maleficence (do no harm), respect and distributive justice were implemented. The study will be carried out in accordance with the Declaration of Helsinki and the principles of good clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Participation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First Group

Thirty patients of COPD smokers patients.

MSCT chest

Intervention Type DIAGNOSTIC_TEST

Multi slice Computed Tomography of the chest

Second group

Thirty patients of COPD ex-smokers patients.

MSCT chest

Intervention Type DIAGNOSTIC_TEST

Multi slice Computed Tomography of the chest

Third group

Thirty patients of COPD non-smokers patients.

MSCT chest

Intervention Type DIAGNOSTIC_TEST

Multi slice Computed Tomography of the chest

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MSCT chest

Multi slice Computed Tomography of the chest

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All patients with chronic obstructive Pulmonary Disease.
2. Patients above 18 years.

Exclusion Criteria

1. Patients with unclear smoking history.
2. Patients with active pneumonia.
3. Patients with acute COPD exacerbation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Somaia Ahmad AbdAllah Ahmad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Somaia Ahmad AbdAllah Ahmad

Main investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Somaia Ahmad AbdAllah Ahmad, M.B.B.Ch

Role: PRINCIPAL_INVESTIGATOR

Assiut University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Somaia Ahmad AbdAllah Ahmad, M.B.B.Ch

Role: CONTACT

01024833938

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Somaia Ahmad

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Innate Immunity in COPD
NCT05743582 RECRUITING
Upright MRI in Lung Disease
NCT03531775 UNKNOWN NA